[1]
2025. Preclinical Evaluation of the Innovative MK-7 NE: Toxicity Assessment and Safety Optimization in In Vivo Models. International Journal of Pharmaceutical Sciences and Drug Research. 17, 3 (May 2025), 216–226. DOI:https://doi.org/10.25004/IJPSDR.2025.170301.